{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T05:08:51Z","timestamp":1773378531612,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1245\/s10434-025-18854-w","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T14:34:34Z","timestamp":1765377274000},"page":"2899-2907","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hepatectomy Plus Chemotherapy or Chemotherapy Alone for Resectable Liver and Unresectable Lung Metastases from Colorectal Adenocarcinoma (LUNA): A Randomized Phase II Trial"],"prefix":"10.1245","volume":"33","author":[{"given":"Ian W.","family":"Folkert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Van K.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Overman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan","family":"Kee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara B.","family":"Antonoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Wei","family":"Tzeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arvind","family":"Dasari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hop","family":"Tran Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine M.","family":"Parseghian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Vilar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Willis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy E.","family":"Newhook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne","family":"Hofstetter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott E.","family":"Kopetz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Nicolas","family":"Vauthey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun Shin","family":"Chun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"issue":"3","key":"18854_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin."},{"issue":"1","key":"18854_CR2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/SLA.0000000000001624","volume":"265","author":"U Leung","year":"2017","unstructured":"Leung U, Gonen M, Allen PJ, et al. Colorectal cancer liver metastases and concurrent extrahepatic disease treated with resection. Ann Surg. 2017;265(1):158\u201365.","journal-title":"Ann Surg."},{"issue":"8","key":"18854_CR3","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.1245\/s10434-021-10109-8","volume":"28","author":"TM Khan","year":"2021","unstructured":"Khan TM, Verbus EA, Rehman SU, Chun YS, Hernandez JM. The role of liver resection for patients with liver and unresectable lung colorectal metastases (LUNA). Ann Surg Oncol. 2021;28(8):4102\u20133.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"18854_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41698-023-00353-4","volume":"7","author":"FA Zeineddine","year":"2023","unstructured":"Zeineddine FA, Zeineddine MA, Yousef A, et al. Survival improvement for patients with metastatic colorectal cancer over twenty years. NPJ Precis Oncol. 2023;7(1):16.","journal-title":"NPJ Precis Oncol."},{"issue":"2","key":"18854_CR5","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.athoracsur.2018.10.028","volume":"107","author":"JR Handy","year":"2019","unstructured":"Handy JR, Bremner RM, Crocenzi TS, et al. Expert consensus document on pulmonary metastasectomy. Ann Thorac Surg. 2019;107(2):631\u201349.","journal-title":"Ann Thorac Surg."},{"issue":"3","key":"18854_CR6","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/annonc\/mdt591","volume":"25","author":"N Hugen","year":"2014","unstructured":"Hugen N, van de Velde CJH, de Wilt JHW, Nagtegaal ID. Metastatic pattern in colorectal cancer is strongly influenced by histological subtype. Ann Oncol. 2014;25(3):651\u20137.","journal-title":"Ann Oncol."},{"key":"18854_CR7","doi-asserted-by":"crossref","unstructured":"Brouquet A, Vauthey JN, Contreras CM, et al. Improved survival after resection of liver and lung colorectal metastases compared with liver-only metastases: a study of 112 patients with limited lung metastatic disease. J Am Coll Surg. 2011; 213(1): 62\u20139; discussion 69-71.","DOI":"10.1016\/j.jamcollsurg.2011.05.001"},{"issue":"1","key":"18854_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","volume":"34","author":"A Cervantes","year":"2023","unstructured":"Cervantes A, Adam R, Rosello S, et al. Metastatic colorectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34(1):10\u201332.","journal-title":"Ann Oncol."},{"issue":"1","key":"18854_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10147-019-01485-z","volume":"25","author":"Y Hashiguchi","year":"2020","unstructured":"Hashiguchi Y, Muro K, Saito Y, et al. Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2020;25(1):1\u201342.","journal-title":"Int J Clin Oncol."},{"key":"18854_CR10","unstructured":"Benson AB, Venook AP, Adam M, Chang GJ, et al. NCCN clinical practice guidelines in oncology: colon cancer. Version 3.2025. Available at: NCCN.org. Accessed 27 April 2025. https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1428"},{"issue":"9","key":"18854_CR11","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1067\/j.cpsurg.2018.08.004","volume":"55","author":"CL Stewart","year":"2018","unstructured":"Stewart CL, Warner S, Ito K, et al. Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure? Curr Probl Surg. 2018;55(9):330\u201379.","journal-title":"Curr Probl Surg."},{"issue":"4","key":"18854_CR12","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/DCR.0b013e318246b08d","volume":"55","author":"CH Kim","year":"2012","unstructured":"Kim CH, Huh JW, Kim HJ, et al. Factors influencing oncological outcomes in patients who develop pulmonary metastases after curative resection of colorectal cancer. Dis Colon Rectum. 2012;55(4):459\u201364.","journal-title":"Dis Colon Rectum."},{"issue":"5","key":"18854_CR13","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1245\/s10434-014-4207-3","volume":"22","author":"Y Mise","year":"2015","unstructured":"Mise Y, Kopetz S, Mehran RJ, et al. Is complete liver resection without resection of synchronous lung metastases justified? Ann Surg Oncol. 2015;22(5):1585\u201392.","journal-title":"Ann Surg Oncol."},{"issue":"10","key":"18854_CR14","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1245\/s10434-006-9023-y","volume":"13","author":"C Charnsangavej","year":"2006","unstructured":"Charnsangavej C, Clary B, Fong Y, Grothey A, Pawlik TM, Choti MA. Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol. 2006;13(10):1261\u20138.","journal-title":"Ann Surg Oncol."},{"key":"18854_CR15","doi-asserted-by":"crossref","unstructured":"Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999; 230(3):309\u201318; discussion 318\u201321.","DOI":"10.1097\/00000658-199909000-00004"},{"issue":"6","key":"18854_CR16","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649\u201355.","journal-title":"Am J Clin Oncol."},{"issue":"1","key":"18854_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11605-013-2369-0","volume":"18","author":"J Shindoh","year":"2014","unstructured":"Shindoh J, Tzeng CW, Aloia TA, et al. Safety and efficacy of portal vein embolization before planned major or extended hepatectomy: an institutional experience of 358 patients. J Gastrointest Surg. 2014;18(1):45\u201351.","journal-title":"J Gastrointest Surg."},{"issue":"2","key":"18854_CR18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205\u201313.","journal-title":"Ann Surg."},{"issue":"6","key":"18854_CR19","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/BF02307088","volume":"2","author":"GM Fuhrman","year":"1995","unstructured":"Fuhrman GM, Curley SA, Hohn DC, Roh MS. Improved survival after resection of colorectal liver metastases. Ann Surg Oncol. 1995;2(6):537\u201341.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"18854_CR20","first-page":"247","volume":"11","author":"MA Khattak","year":"2012","unstructured":"Khattak MA, Martin HL, Beeke C, et al. Survival differences in patients with metastatic colorectal cancer and with single site metastatic disease at initial presentation: results from South Australian clinical registry for advanced colorectal cancer. Clin Colorectal Cancer. 2012;11(4):247\u201354.","journal-title":"Clin Colorectal Cancer."},{"issue":"6","key":"18854_CR21","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.3390\/cancers16061098","volume":"16","author":"HH Schulz","year":"2024","unstructured":"Schulz HH, Dijkstra M, van der Lei S, et al. Local treatment of colorectal liver metastases in the presence of extrahepatic disease: survival outcomes from the Amsterdam colorectal liver met registry (AmCORE). Cancers. 2024;16(6):1098.","journal-title":"Cancers."},{"issue":"3","key":"18854_CR22","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/jso.27944","volume":"131","author":"KM Mahuron","year":"2025","unstructured":"Mahuron KM, Hernandez MC, Wong P, et al. Liver resection with extrahepatic disease: a population-based analysis of thoughtful selection. J Surg Oncol. 2025;131(3):443\u20139.","journal-title":"J Surg Oncol."},{"issue":"3","key":"18854_CR23","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.hpb.2019.07.004","volume":"22","author":"M Albertsmeier","year":"2020","unstructured":"Albertsmeier M, Riedl K, Stephan AJ, et al. Improved survival after resection of colorectal liver metastases in patients with unresectable lung metastases. HPB. 2020;22(3):368\u201375.","journal-title":"HPB."},{"issue":"3","key":"18854_CR24","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1245\/s10434-020-09459-6","volume":"28","author":"MI Chavez","year":"2021","unstructured":"Chavez MI, Gholami S, Kim BJ, et al. Two-stage hepatectomy for bilateral colorectal liver metastases: a multi-institutional analysis. Ann Surg Oncol. 2021;28(3):1457\u201365.","journal-title":"Ann Surg Oncol."},{"issue":"13","key":"18854_CR25","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/S1470-2045(15)00122-9","volume":"16","author":"C Cremolini","year":"2015","unstructured":"Cremolini C, Loupakis F, Antoniotti C, et al. FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study. Lancet Oncol. 2015;16(13):1306\u201315.","journal-title":"Lancet Oncol."},{"issue":"1","key":"18854_CR26","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.50996","volume":"6","author":"C Shadbolt","year":"2023","unstructured":"Shadbolt C, Naufal E, Bunzli S, et al. Analysis of rates of completion, delays, and participant recruitment in randomized clinical trials in surgery. JAMA Netw Open. 2023;6(1):e2250996.","journal-title":"JAMA Netw Open."},{"issue":"1","key":"18854_CR27","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1186\/s13063-021-05403-5","volume":"22","author":"L Davies","year":"2021","unstructured":"Davies L, Beard D, Cook JA, Price A, Osbeck I, Toye F. The challenge of equipoise in trials with a surgical and non-surgical comparison: a qualitative synthesis using meta-ethnography. Trials. 2021;22(1):678.","journal-title":"Trials."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18854-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18854-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18854-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:47:10Z","timestamp":1773330430000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18854-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["18854"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18854-w","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"27 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work was supported by the National Institutes of Health (P30 CA016672). Van Morris has received research funding (to institution) from Pfizer, Novartis, Bicara Pharmaceuticals, Bristol Myers Squibb, and BioNTech, and has had consulting\/advisory relationships with Pfizer, BMS, AbbVie, GSK, Exelixis, BioNTech, AmMax Bio, Scandion Oncology, and Bicara. Eduardo Vilar-Sanchez has had a consulting or advisory role with Janssen Research and Development, Recursion Pharma, Guardant Health, Rising Tide Foundation, Nouscom, AbbVie, Moderna, and Permanence Bio. EV has received research support from Janssen Research and Development. EV has equity in Permanence Bio. Scott Kopetz has ownership interest in Lutris, Frontier Medicines, and Navire; is a consultant for Genentech, Merck, Boehringer Ingelheim, Bayer Health, Pfizer, Mirati Therapeutics, Flame Biosciences, Carina Biotech, Frontier Medicines, Replimune, Bristol-Myers Squibb-Medarex, Amgen, Tempus, Harbinger Oncology, Zentalis, AVEO, Tachyon Therapeutics, Agenus, Revolution Medicines, Kestrel Therapeutics, Roche, Arcus Biosciences, AstraZeneca Pharmaceuticals, BeiGene, Clasp Therapeutics, Cytovation, Dewpoint Therapeutics, Marengo Therapeutics, SageMedic, Servier, Sibylla, T-Cypher Bio, XAIRA, AmMax Bio, and Ikena; and has received research funding from Guardant Health, Genentech\/Roche, EMD Serono, Amgen, Lilly, Daiichi Sankyo, Pfizer, Boehringer Ingelheim, BridgeBio, Zentalis, BioMed Valley, Johnson & Johnson, BMS, Cardiff, Jazz Pharmaceuticals, and Frontier Medicines.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}